MAPS remains “optimistic about treatment coverage, but not naive for the worries”. MDMA therapy will require distinctive coverage beneath coverage, medicare, and medicaid. More information on protection will occur as we near FDA approval. When will other countries authorize MDMA and on what terms?Alongside these therapies, acceptance and motiva